Sakura, Japan

Norio Katayama




Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Norio Katayama to Vaccine Development**

Introduction

Norio Katayama, an esteemed inventor based in Sakura, Japan, has made significant strides in the field of vaccine development. With a total of two patents to his name, his innovative work is centered around finding effective therapeutic methods to combat bacterial infections, particularly mycoplasma infections.

Latest Patents

Norio Katayama's latest patent revolves around a vaccine designed specifically for mycoplasma infections. This groundbreaking vaccine boasts a high therapeutic effect and exceptional safety profiles. The invention focuses on the development of mimic particles that serve as an effective vaccine by inducing a strong immunological response in living organisms. These bacterium-mimic particles, which contain lipid antigens specific to pathogenic bacteria, can be formulated into liposome particles. The administration of these mimic particles is expected to enhance immune response and serves as an excellent approach for both prevention and treatment of infections.

Career Highlights

Throughout his career, Norio Katayama has held notable positions at prestigious organizations such as the National Institute of Infectious Diseases and M Bio Technology Inc. His work in these institutions has been pivotal in advancing research and innovation in infectious disease treatment and vaccine development.

Collaborations

Norio Katayama has collaborated with esteemed colleagues, including Kazuhiro Matsuda and Koji Ichiyama. Their joint efforts have undoubtedly contributed to the progress of innovative solutions in the realm of infectious diseases, enhancing the overall effectiveness of therapeutic methods.

Conclusion

Norio Katayama's contributions through his patents exemplify the vital role of inventors in the healthcare sector. His innovative work on vaccines for mycoplasma infections potentially paves the way for a healthier future by addressing critical needs in bacterial infection treatments. As research and development in this field continue, the influence of Katayama's inventions is poised to make lasting impacts.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…